 |
|
|
|
|
|
|
|
 |
Results for 'Peptides 2006: New Applications in Discovery, Manufacturing, and Therapeutics' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Next Generation Protein Engineering and Drug Design
Strategies to boost efficacy and improve drug delivery
|
February 2007 |
£1495 |
35 % |
Burger's Medicinal Chemistry and Drug Discovery
6 Volume Set
|
March 2003 |
£1331 |
30.1 % |
Market for Bioengineered Protein Drugs; The
|
January 2007 |
£2410 |
23.1 % |
Outlook for RNAi, 2007
siRNA and miRNA in biology, diagnostics and therapeutics
|
June 2007 |
£1495 |
22.05 % |
Emerging Drug Discovery Technologies
Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
|
January 2005 |
£1495 |
21.35 % |
The Outlook For RNAi
Accelerating drug discovery and the development of RNAi therapeutics
|
January 2005 |
£1495 |
17.5 % |
Proteomics
Technologies, Markets and Companies
|
September 2008 |
£1875 |
16.8 % |
RNAi
Technologies, Markets and Companies
|
September 2008 |
£1605 |
15.75 % |
Preclinical Cancer Therapeutics 2007
Decoding Next Generation Drug Targets for Market Success
|
December 2006 |
£1600 |
15.75 % |
Modern Biopharmaceuticals
Design, Development and Optimization, 4 Volumes
|
September 2005 |
£440 |
14.7 % |
Fastest Growing Biotechnology Companies, The
Growth Strategies, Comparative Analyses and Company Profiles
|
March 2008 |
£1995 |
14.7 % |
Cytogenetics
technologies,markets and companies
|
September 2008 |
£1070 |
14.35 % |
Antiviral Therapeutics
Technologies, Markets and Companies
|
September 2008 |
£1500 |
13.3 % |
Drug Discovery
Current trends and future prospects
|
February 2001 |
£300 |
13.3 % |
Global Market for Antimicrobials and Antifungals; The
Challenging Resistance to 2016
|
December 2006 |
£1600 |
12.6 % |
How Drugs Are Developed
3rd Edition
|
January 2007 |
£1095 |
12.25 % |
Pain Therapeutics
Drugs, Markets and Companies
|
September 2008 |
£1605 |
10.5 % |
Personalized Medicine
scientific & commercial aspects
|
September 2008 |
£2140 |
9.8 % |
Molecular Diagnostics
Technologies, Markets and Companies
|
September 2008 |
£2410 |
9.1 % |
Drug Delivery in Central Nervous System Diseases
technologies,markets and companies
|
September 2008 |
£1340 |
9 % |
Antibiotics and Drug Resistance 2008
Drug Innovation and the Strategy to Combat - Antibiotic Resistance Mechanisms
|
January 2008 |
£1499 |
8.05 % |
Nitric Oxide
Therapeutics, Markets and Companies
|
September 2008 |
£1500 |
7.7 % |
Executive Guide to Molecular Imaging; The
|
April 2005 |
£395 |
6.3 % |
Cell Therapy
Technologies, Markets and Companies
|
September 2008 |
£2410 |
5.95 % |
|
|
|
|
